Form 4: LeMaitre Vascular Director Acquires Shares Upon PSU Settlement and Dividend Equivalent Release
SEC Form 4 Filing
Director Bridget A. Ross acquired shares of LeMaitre Vascular common stock following the settlement of a Performance Share Unit (PSU) award and the release of dividend equivalent rights.
Summary
- On February 28, 2025, Bridget A. Ross, a director of LeMaitre Vascular, Inc. (LMAT), acquired 204 shares of common stock upon the settlement of a Performance Share Unit (PSU) award.
- The PSU award was granted on December 8, 2023, and vests in installments.
- Ross also acquired 1 share upon the release of dividend equivalent rights related to the PSU award.
- The price for both transactions was $0.
- Following these transactions, Ross directly owns 2,916 shares of LeMaitre Vascular common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of share acquisition by a director due to PSU settlement, which is part of the standard compensation package. It doesn't indicate any significant positive or negative outlook.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers regarding their holdings of the company's stock.
Comparison to Industry Standards
- Comparing LeMaitre Vascular's insider activity to companies like Medtronic (MDT) or Boston Scientific (BSX) would require analyzing their respective Form 4 filings over a similar period.
- The vesting schedules and terms of PSU awards are generally benchmarked against industry practices to attract and retain key personnel.
- The number of shares acquired is relatively small, suggesting this is part of a regular compensation or incentive plan rather than a significant investment decision.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- It provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| December 8, 2023 | Date of grant for the Performance Share Unit (PSU) award. |
| December 5, 2024 | Date of execution for the Limited Power of Attorney. |
| February 28, 2025 | Date of transaction: Acquisition of shares upon PSU settlement and release of dividend equivalent rights. |
| March 04, 2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.